Ajanta Pharma (NSE: AJANTPHARM, BSE: 532331) buyback 2022 was announced on 28 December 2021. The buyback record date is 14 January 2022. Ajanta Pharma Limited is a multinational company engaged in the development, manufacturing, and marketing of pharmaceutical formulations. They have a presence in India, the United States, Africa, South East Asia, West Asia, and CIS. The company was established in 1973. Ajanta Pharma reported revenue of 2,916 crores in 2022-2021. The company has over 7000 employees working globally. They have 7 manufacturing facilities in India. They have designed a customized basket of products for each of these markets and serve a wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products.
Ajanta Pharma Buyback 2022 Offer Details:
| Buyback Record Date: | 14 Jauaary2022 |
| Buyback Open Date: | 3 February 022 |
| Buyback Close Date: | 16 February 022 |
| Buyback Offer: | ₹285.60 Crores |
| Buyback Offer Size: | 1.29% |
| Number of Shares: | 11,20,000 Equity Shares |
| Share Face Value: | ₹2 per equity share |
| Buyback Price: | ₹2550 per equity share |
| Buyback Type: | Tender Offer |
Ajanta Pharma Financial Report:
| ₹ in Crores | |||||
| Revenue | Expense | PAT | |||
| 2019 | ₹2055 | ₹1489 | ₹387 | ||
| 2020 | ₹2588 | ₹1904 | ₹468 | ||
| 2021 | ₹2890 | ₹1889 | ₹654 | ||
Ajanta Pharma Buyback Eligible Share Holders:
Ajanta Pharma Buyback Registrar
Ajanta Pharma Buyback Lead Managers
- Vivro Financial Services Private Limited
Ajanta Pharma Company Address
Ajanta Pharma Buyback 2022 FAQs:
Note: If anything you want to know about the buyback offer you can refer to the Ajanta Pharma buyback offer documents.
